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Abstract
Background: Sepsis likely contributes to the high burden of infectious disease morbidity and mortality in low income
countries. Data regarding sepsis management in sub-Saharan Africa are limited. We conducted a prospective observational
study reporting the management and outcomes of severely septic patients in two Ugandan hospitals. We describe their
epidemiology, management, and clinical correlates for mortality.
Methodology/Results: Three-hundred eighty-two patients fulfilled enrollment criteria for a severe sepsis syndrome. Vital signs,
managementandlaboratoryresultswererecorded.Outcomesmeasuredincludedin-hospitalandpost-dischargemortality. Most
patients were HIV-infected (320/377, 84.9%) with a median CD4+ T cell (CD4) count of 52 cells/mm
3 (IQR, 16–131 cells/mm
3).
Overall mortality was 43.0%, with 23.7% in-hospital mortality (90/380) and 22.3% post-discharge mortality (55/247). Significant
predictors of in-hospital mortality included admission Glasgow Coma Scale and Karnofsky Performance Scale (KPS), tachypnea,
leukocytosis and thrombocytopenia. Discharge KPS and early fluid resuscitation were significant predictors of post-discharge
mortality. Among HIV-infected patients, CD4 count was a significant predictor of post-discharge mortality. Median volume of
fluid resuscitation within the first 6 hours of presentation was 500 mLs (IQR 250–1000 mls). Fifty-two different empiric
antibacterial regimens were used during the study. Bacteremic patients were more likely to die in hospital than non-bacteremic
patients(OR1.83,95% CI=1.01–3.33). Patientswith Mycobacterium tuberculosis (MTB)bacteremia (25/249) had higher in-hospital
mortality (OR 1.97, 95% CI=1.19–327) and lower median CD4 counts (p=0.001) than patients without MTB bacteremia.
Conclusion: Patients presenting with sepsis syndromes to two Ugandan hospitals had late stage HIV infection and high
mortality. Bacteremia, especially from MTB, was associated with increased in-hospital mortality. Most clinical predictors of in-
hospital mortality were easily measurable and can be used for triaging patients in resource-constrained settings.
Procurement of low cost and high impact treatments like intravenous fluids and empiric antibiotics may help decrease
sepsis-associated mortality in resource-constrained settings.
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Introduction
Sepsis in high income countries (HICs) accounts for a significant
burden of disease and mortality and has been implicated as the
leading cause of non-cardiac death amongst critically ill patients in
these settings [1–4]. Similar epidemiologic data on sepsis in low
and middle income countries (LMICs) are unavailable. Several
studies from sub-Saharan Africa (SSA) reveal an association
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and mortality [5–12]. While the ultimate cause of death is not
identified in these patients, it is likely that a large proportion
succumb to severe sepsis [4].
In HICs, algorithmic approaches to sepsis management which
focus on early diagnosis and antimicrobial treatment, aggressive
fluid resuscitation and concomitant monitoring of such parameters
as central venous pressure, central venous oxygen saturation, and
hematocrit can decrease sepsis-associated mortality [13,14]. In
LMICs, data regarding the management and outcomes of sepsis
syndromes are limited [15]. Factors thought to contribute to poor
outcomes of critically ill patients in these settings include limitations
due to cost, deficiency of diagnostic laboratories, microbiologic and
radiologic capabilities and delayed presentation of severely sick
patients [6,16,17]. Notably, a retrospective hospital chart review
from Zambia revealed that 79 (86%) of 92 hypotensive patients with
suspected sepsis received no intravenous (IV) fluid resuscitation
[18]. Additionally, a study of bacteremic children in Tanzania
highlighted increased mortality when empiric antibiotics were
discordant with antibiotic susceptibility profiles [19].
The scarcity of data on this topic in developing countries
necessitates further studies to evaluate cost-effective approaches to
sepsis in these settings [20]. While HIC approaches to sepsis are
not feasible in the current resource-constrained environment of
SSA, the timely provision of IV fluid resuscitation and empiric
antibiotics alone may improve outcomes [21]. We conducted the
first prospective observational study in an LMIC of severely septic
adults admitted to the medical wards of two government hospitals
in Uganda. The objectives of the study were to 1) identify clinical
predictors for in-patient and post-discharge mortality among
hospitalized Ugandan patients with severe sepsis, and 2) describe
the epidemiology, management, and etiology of sepsis in this
setting. Given the resource constraints in these hospitals, we paid
particular attention to potentially cost-effective interventions such
as initial fluid resuscitation and empiric antibiotic administration.
Methods
Ethics statement
Approval was obtained from the University of Virginia
Institutional Review Board, Mulago Hospital Office of Director,
Makerere University Faculty of Medicine Research Ethics Com-
mittee and Infectious Disease Institute Scientific Research Com-
mittee, and Uganda National Council of Science and Technology.
Site descriptions
Mulago Hospital is a 1500-bed national referral hospital in
Kampala, Uganda. Approximately 64% of medical ward patients
are infected with human immunodeficiency virus type 1 (HIV)
[22]. Masaka Regional Referral Hospital (MRRH) is a 330-bed
regional referral hospital in Masaka, Uganda (125 kilometers
southwest of Kampala) serving five surrounding districts. Both
Mulago and Masaka Hospitals exist under the auspices of the
Ministry of Health and were selected out of convenience as
representations of a national and regional referral government
hospital in Uganda.
Site resource capacity
In HICs, sepsis management requires close monitoring of
central venous pressure, mean arterial pressure (MAP), urine
output, central venous oxygen saturation, peripheral oxygen
saturation, and hemoglobin [14]. During the course of the study,
the only parameters measurable were MAP and hemoglobin. Pulse
oximeters were sparse at Mulago and not available at MRRH. At
Mulago Hospital, one oxygen tank existed for the emergency
medicine ward (,50 beds) from which nasal cannulae were used
to simultaneously provide oxygen for up to 5 hypoxic or
tachypneic patients. No oxygen tanks were available on the
medical wards in MRRH. Since vasopressor or inotropic
medications were scarce, cardiovascular support medications,
when available (e.g., dopamine and epinephrine), were rarely
utilized, especially on the medical ward. There was a 5-bed
intensive care unit (ICU) present at Mulago Hospital but not one
at MRRH. The Mulago ICU was mainly available for surgery and
private patients. Thus, adult medical patients, especially those with
HIV and tuberculosis, were rarely admitted to the ICU.
Patient recruitment
From July 2006 until November 2006, patients were enrolled
consecutively on weekdays during daytime hours from the
Accident and Emergency Departments of both hospitals. Patients
were included if they were $18 years of age, admitted to a medical
ward and had: 1) a suspected infection, 2) $2 of the following:
axillary temperature (TMP) .37.5uCo r,35.5uC; heart rate (HR)
.90 beats/min; or respiratory rate (RR) .20 breaths/min and 3)
systolic blood pressure (SBP) #100 mmHg. Patients were
excluded if they had an acute cerebrovascular event, gastrointes-
tinal hemorrhage, or required admission to a non-medical ward.
Written informed consent was obtained from each patient; if
patients were unable to provide consent, written consent was
obtained from their attendant. Attendants were most often
comprised of the patient’s next of kin but also included friends
or neighbors. Patients who were unable to provide consent and not
accompanied by an attendant were not enrolled in the study.
Data collection
Patients were enrolled based on parameters measurable at the
time of evaluation. These parameters included HR, TMP, RR,
and blood pressure recorded at enrollment and 6 and 24 hours
afterwards. White blood cell (WBC) concentration was not
included in the entry criteria due to unavailability at the time of
admission. WBC concentration, however, was measured and used
to ultimately assess whether patients fulfilled previously established
criteria for sepsis [23]. Along with Glasgow Coma Scale (GCS),
admission Karnofsky Performance Status (KPS) was used to assess
admission morbidity; discharge KPS was used to assess morbidity
at discharge [24]. Use of KPS as a morbidity assessment scale has
been well described in oncology literature and has been shown to
predict survival among Ugandan HIV-infected patients within the
outpatient setting [25,26].
While the in-hospital medical team was responsible for all
clinical decisions regarding patient management, the study team
recorded patient management details until discharge or death.
Specifically, the study team recorded the amount of IV fluid
resuscitation administered in the first 6 and 24 hours and type of
empiric antimicrobial agents given at presentation. In addition,
information regarding blood transfusions and radiologic studies
was recorded when available. Appropriate empiric antibiotic
therapy was defined as use of a regimen to which the isolate was
found to be sensitive in susceptibility testing. All treatments given
were paid for by either the hospital or, in cases (e.g., blood
transfusions) where the hospital could not provide the treatment,
by the patient or family members.
The primary outcome measure was mortality, analyzed as in-
hospital and post-discharge mortality (among patients who
survived to discharge). Attempts were made to contact patients
30 days after discharge by telephone for information regarding
outpatient survival. If patients did not have access to a telephone,
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return to the Accident and Emergency Department for a post-
discharge, 30-day assessment.
Laboratory evaluation, reliability and validity
Due to the lack of a centralized laboratory for study patients, the
services of several organizations were utilized for laboratory
testing. HIV antibody testing was performed on site at each
hospital using Determine [Abbott Laboratories, Tokyo, Japan]
and Statpak [Chembio Diagnostic Systems, Inc, Medford, USA].
If results of the initial antibody tests were equivocal, Unigold
[Trinity Biotech plc, Bray, Ireland] was used for a tie breaker.
Malaria thick smears were also performed, as previously described
[27]. Point-of-care portable whole blood lactate (PWBL) (Accu-
trend portable lactate analyzer; Sports Resource Group, Inc.,
USA) testing was performed on site using blood collected by
fingerstick, as previously described [28].
Mulago site
At the Mulago site, Ebenezer Limited Clinical Laboratory
(Kampala, Uganda), accredited by the South African National
Accreditation System (SANAS), provided results for general
laboratory evaluations including complete blood counts (CBC)
with differentials (Sysmex KX-21, TOA Medical Electronics,
Kobe, Japan); CD4+ T cell (CD4) counts (FACSCount System,
BD Biosciences, San Jose, CA); serum lactic acid and bicarbonate
(Diagnostic Systems International, Holzheim, Germany); cortisol
(BioMerieux s.a., Marcy L’Etoile, France); albumin, blood
urea nitrogen and creatinine (Cobas Mira Plus CC Analyzer,
Roche Diagnostics, North America); and sodium, potassium, and
chloride (HumaLyte, Human Diagnostics Worldwide, Wiesbaden,
Germany).
Aerobic cultures were performed at the Makerere University
microbiology laboratory; mycobacterial cultures were performed
at the Joint Clinical Research Center (Kampala, Uganda). Both
these laboratories have enrolled in International Organization for
Standardization (ISO) processes and participate in World Health
Organization (WHO) External Quality Assurance for microscopy,
culture and drug susceptibility testing. Standard American Type
Culture Collection (ATCC) isolates were used for quality control.
Masaka site
At MRRH, fewer facilities exist for laboratory testing than at
Mulago Hospital. As a result, only CBCs (Humacount, Human
Diagnostics Worldwide, Wiesbaden, Germany) and CD4 testing
(Guava Technologies, Hayward, CA) were performed at MRRH
using nearby organizations with laboratory capabilities.
Aerobic cultures were obtained at the nearby Rakai Health
Sciences Project (RHSP) which participates in external quality
assurance programs provided by the College of American
Pathologists (CAP) and maintained satisfactory performance
throughout the study period on all culture and antibiogram
surveys. RHSP provides quality assurance and control for
laboratories in the area including the Uganda Cares Initiative,
Masaka where CD4 counts were performed and AID Child,
Masaka, where CBCs were performed.
Microbiology
Once enrolled at Mulago Hospital, 5–7 mLs of blood were
aseptically inoculated into 2 aerobic blood culture bottles
(Liofilchem s.r.l. Bacteriology products, Roseto, Italy). Subcultur-
ing and species identification were performed using standard
methods. Sensitivities were determined based on turbidity
compared with a MacFarland Standard and inoculated on
Mueller-Hinton agar (Liofilchem s.r.l. Bacteriology products,
Roseto, Italy) for evaluation of zone diameters associated with
antimicrobial discs.
For Mulago patients only, another 3–5 mLs of blood were
aseptically inoculated into BACTEC Myco/F Lytic culture vials
(Becton Dickinson, Sparks, Maryland, USA) for mycobacterial
cultures. Mycobacteria detected in blood were incubated and
monitored in a BACTEC 9120 instrument (Becton Dickinson,
Sparks, Maryland, USA). Positive mycobacterial cultures were
further identified as Mycobacterium tuberculosis (MTB) complex by
IS6110 PCR amplification using a PTC-200 Peltier Thermal
Cycler (MJ Research, Reno, NV, USA).
At MRRH, ten mLs of blood were aseptically inoculated into
two aerobic blood culture bottles (BBL Septi-Chek, Becton
Dickinson, Sparks, MD). BBL Septi-Chek Slides (Becton Dick-
inson, Sparks, MD) were then attached to culture bottles and
observed for primary growth which was subcultured and speciated
using standard methods. Susceptibility testing was performed using
the ATB system (Biomerieux, France). To determine susceptibility
to chloramphenicol, Mueller-Hinton agar disc diffusion was used
on Gram negative isolates as this antibiotic is not included in the
ATB Gram negative panel.
Bacteremia was defined as bacterial isolation from one or more
blood culture bottles. Cultures growing coagulase-negative staph-
ylococci were not included in the analyses.
Statistical analysis
Data were entered into a spreadsheet using Epi-Info (version
6.04d, Centers for Disease Control and Prevention, USA) and
analyzed using SPSS software (version 15.0, SPSS Inc., USA).
Descriptive statistics were reported as mean and standard
deviation for normally distributed variables and median and
interquartile range (IQR) for variables not normally distributed.
The x2 analysis of variance was used to compare differences for
categorical variables. Odds ratios (OR) with 95% confidence
intervals (CI) were calculated. The Student’s paired sample t-test
was used to compare mean differences between continuous
variables. The Mann-Whitney U test was used to compare non-
parametric continuous variables (e.g., CD4 count). Statistical
significance was defined as p,0.05. Variables with clinically
relevant cut-off points were dichotomized.
In order to determine independent predictors of in-hospital
mortality for the general study population, numerous variables were
assessed including demographic characteristics (sex, mean age,
marital status, education and hospital site), measurements of clinical
status (GCS,15, admission KPS, fulfillment of $3 SIRS criteria,
HR.110 bpm, RR.30 brpm, TMP.37.5 C, TMP,35.5 C,
MAP,50 mmHg); laboratory studies (aerobic culture positivity,
HIV-1 status, WBC.12,000 cells/mL, WBC,4,000 cells/mL,
malaria blood smear positivity, platelets,150,000 cells/mL, and
level of hemoglobin); and management (volume of fluid provided at
6 and 24 hours ($1 L vs.,1 L), time to administration of fluid
(,1 hour vs. $1 hour), whether or not empiric antibiotics were
administered, and time to administration of empiric antibiotics
(,1 hour vs. $1 hour). Additional covariates were assessed to
determine independent predictors of post discharge mortality
including discharge KPS and length of hospitalization.
Univariate analyses were used to identify which variables with a
p-value less than 0.20 would be included in the multivariate
models. Stepwise backward logistic regression was used to
determine whether these covariates were independent predictors
of mortality; covariates were eliminated when p-values were
greater than or equal to 0.05.
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and post-discharge mortality among HIV-infected patients from
both hospital sites. Covariates assessed at the univariate level
included CD4 count along with the same variables evaluated in
the generalized patient models.
For patients from the Mulago Hospital site with additional
laboratory testing, univariate analyses were used to assess whether
patients’ laboratory results at admission were related to in-hospital
and post discharge 30-day mortality. Covariates significant at the
p,0.20 level were entered into a multivariate model which adjusted
for covariates found to be significant independent predictors of in-
hospital and post-discharge mortality at Mulago Hospital.
Results
Background Characteristics
Of 385 patients eligible for enrollment, 382 patients were
enrolled (250 from Mulago Hospital, 132 from MRRH). Three
patients were excluded because of transfer to a surgery ward (see
Figure 1). Two patients absconded during their hospitalization and
were lost to follow up.
The majority of patients enrolled were ARV-naı ¨ve, HIV-
infected women (see Table 1). The most frequent chief complaints
at the time of admission were fever (39.2%, 149/380), cough
(19.6%, 75/380), and diarrhea (11.0%, 42/380). Attendants
accompanied 91.1% (348/382) of patients. While the majority of
attendants were comprised of next of kin, 41 of 348 patients were
accompanied by friends or neighbors.
Mortality
From hospital census reports during the study period, all-
cause in-hospital mortality for the adult medical wards was
15.4% (1054 of 6856 patients) [29,30]. Background post-
discharge mortality data were not available from either hospital
site. Of the 380 patients followed in this study, ninety (23.7%)
died while hospitalized. Median length of hospital stay for the
remaining 290 patients who survived to discharge was 6 days
(IQR, 3–10). Of these patients, 43 (14.8%) were lost to follow-
Figure 1. Flow diagram for study eligibility and follow-up to 30 days post-discharge.
doi:10.1371/journal.pone.0007782.g001
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Hospital.
Fifty-five (22.3%) of the remaining 247 patients died within 30
days of discharge. Thus, 145 (43.0%) of 337 patients contributed
to overall mortality with the majority of deaths occurring soon
after hospital admission. Of the 145 total deaths, 15 (10.3%)
occurred in the first day, 42 (30%) occurred within 3 days after
admission, 70 (48.3%) occurred within 7 days after admission,
and 105 (72.4%) occurred within 28 days after admission.
Clinical Correlates of Mortality
Univariate analysis was used to assess the predictive value of
variables with respect to in-hospital mortality in the general study
patient population (see Table 2). In multivariate analysis,
independent, significant predictors of in-hospital mortality (see
Table 3) included GCS,15, decreased admission KPS (see
Figure 2), RR.30 breaths/min, WBC.12,000 cells/mL, and
platelets,150,000 cells/mL. These variables together explained
22% (Nagelkerke R
2) of the variance associated with in-hospital
mortality.
Univariate analysis was also used to assess the predictive
value of variables with respect to post-discharge mortality (see
T a b l e4 ) .As e p a r a t em u l t i v a r i a t ea n a l y s i ss h o w e dt h a t
independent, significant predictors of post-discharge mortality
were decreased discharge KPS and earlier fluid resuscitation
(,1h o u rv s .$1 hour) (see Table 5). These variables together
explained 24% (Nagelkerke R
2) of the variance associated with
post-discharge mortality.
A separate model including only HIV-infected patients (n=320)
showed that CD4 count (p=0.012), discharge KPS (p,0.001) and
early fluid resuscitation (p=0.031) were significantly associated
with post-discharge mortality (data not shown). CD4 count did not
contribute to prediction of in-hospital mortality among HIV-
infected patients.
Fluid Resuscitation
Overall, only 46 (12%) of 381 patients received more than
1500 mLs of IV fluid within the first 6 hours of presentation. The
median volume of IV crystalloid received within the first 6 hours
was 500 mLs (IQR=250–1000) and at 24 hours was 1000 mLs
(IQR=500–1500). Only 4 of 382 patients received a blood
transfusion within their first 6 hours of presentation.
Given the minimal IV fluid provided overall, no survival benefit
was observed across strata of fluid volume in the general study
population. Of the 25 patients who had confirmed Gram negative
bacteremia, however, overall mortality was significantly decreased
in patients receiving at least 1 L of fluid when compared to
patients receiving ,1 L of fluid [20% (2/10) vs. 66.7% (10/15),
p=0.022; OR 0.1, 95% CI=0.02–0.8].
Timing of fluid resuscitation was an important predictor of
in-hospital mortality at the univariate level and post-discharge
mortality at the multivariate level. About half (53%) of patients
received at least some IV fluid within the first hour of
presentation while 28% waited between 1 to 6 hours; 14% of
patients received no fluid within the first 6 hours of presenta-
tion. Patients receiving initial fluids in ,1h o u rf r o mp r e s e n -
Table 1. Descriptive characteristics of hospital sites.
Characteristic Combined (n=382)
* Mulago (n=250)
* Masaka (n=132)
*
Demographics:
Age in years; mean (SD) 34.8 (11.2) 34.3 (10.51) 35.6 (12.3)
Number female (%) 226 (59.2%) 149 (59.6%) 77 (58.3%)
Inclusion criteria:
Number fulfilling $3 SIRS criteria (%) 317 (83.2%) 212 (84.8%) 105 (80.2%)
Admit temp in uC; mean (SD) 37.6 (1.5) 37.7 (1.6) 37.4 (1.4)
Admit HR in beats/min; mean (SD) 120.1 (20.7) 122.3 (20.7) 115.6 (19.8)
Admit RR in breaths/min; mean (SD) 36.9 (11.8) 37.4 (12.1) 35.9 (11.3)
Admit WBC in cells/mL; mean (SD) 7478.5 (6912.5) 6926.9 (5962.6) 8554.5 (8525.5)
Admit MAP in mmHg; mean (SD) 59.5 (16.7) 56.8 (17.9) 64.6 (12.7)
Admit SBP in mmHg; mean (SD) 81.9 (15.8) 79.2 (16.8) 87.1 (12.1)
Admit DBP in mmHg; mean (SD) 48.15 (18.5) 45.37 (19.9) 53.40 (14.3)
HIV descriptors:
Number HIV-infected (%) 320 (84.9%) 213 (85.9%) 107 (82.9%)
CD4 count in lymphocytes/mm
3; median (IQR)
{ 52.0 (16.0–131.0) 42.0 (10.2–103.5) 65 (25.0–98.0)
Number aware of HIV status (%)
{ 216 (67.5%) 154 (72.3%) 62 (57.9%)
Number on HAART (%)
{ 38 (11.9%) 28 (13.1%) 10 (9.3%)
Number within WHO, stage IV (%)
{ 179 (57.4%) 128 (62.4%) 51 (47.7%)
Other Clinical Variables:
Admit Karnofsky Performance Score; mean (SD) 46.4 (16.6) 43.2 (16.1) 52.3 (16.0)
Portable whole blood lactate in mmol/L; mean (SD)
‘ 3.8 (2.5) 4.1 (2.6) 3.7 (2.6)
Number with positive malaria blood smear (%) 51 (13.5%) 24 (9.6%) 27 (20.9%)
* Due to the occurrence of missing data found in ,2% of the variables, numbers may not add up to total n.
{ Denominator is Number HIV-infected.
‘ Portable whole blood lactate levels were not obtained on all patients [combined (n=194); Mulago (n=70); Masaka (n=124)].
doi:10.1371/journal.pone.0007782.t001
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patients receiving fluids at or after 1 hour [28.6% (57/199) vs.
18.2% (33/181), p=0.01; OR 1.8, 95% CI=1.08–3.02]. When
adjusted for significant predictors of in-hospital mortality,
however, the relationship between time to fluid resuscitation
and in-hospital mortality did not remain significant. To
determine whether sicker patients were more likely to receive
earlier fluid resuscitation, time to fluid resuscitation was
evaluated in a multivariate analysis with significant predictors
of in-hospital mortality comprising the model. Independent,
significant predictors of early fluid resuscitation were admission
KPS (OR 0.7 per 10-unit increase, 95% CI=0.6–0.8) and
platelets ,150,000 cells/mL (OR 1.8, 95% CI=1.1–2.9).
Empiric Antibacterial Administration
During the course of the study, availability of antibacterial
therapy at any given time was inconsistent. Accordingly, fifty-two
different empiric antibacterial combinations were used by the
admitting doctors caring for the study patients (see Figure 3). In
total, 84.8% (319/376) of patients received some form of empiric
antibacterials. There was no overall mortality benefit found
between patients receiving any of the 52 available empiric
antibacterial regimens compared to patients receiving no empiric
antibacterials (23.8% vs. 22.6%, p=0.85).
While 61% of these patients received antibacterials within
the first 6 hours, only 37.8% received them within the
first hour of presentation. Earlier administration of antibacte-
Table 2. Univariate analysis of clinical predictors for in-hospital mortality.
Variable Subcategory Died (n=90)
* Survived (n=290)
* OR (95% CI) p
Patient Demographic Characteristics
Female [n (%)] Female 51 (56.7) 173 (59.7) 0.9 (0.5–1.4) 0.62
Age [mean years (SD)] 35.3 (10.4) 34.6 (11.3) n/a 0.64
Marital Status [n (%)] Married or in Relationship 36 (40.9) 151 (52.8) 0.6 (0.4–1.0) 0.05
Unmarried or not in Relationship 52 (59.1) 135 (47.2)
Education [n (%)] None 10 (4.4) 22 (7.7) 0.9 (0.6–1.3) 0.73
Primary School 53 (60.2) 180 (63.2)
Secondary School 24 (27.3) 78 (27.4)
University 1 (1.1) 5 (1.8)
Hospital Site [n (%)] Mulago 61 (67.8) 188 (64.8) 1.1 (0.7–1.9) 0.61
Masaka 29 (32.2) 102 (35.2)
Medical Status at Admission
Glasgow Coma Score ,15 [n (%)] 17 (18.9) 15 (5.2) 4.3 (2.0–9.0) ,0.001
Karnofsky Score [mean (SD)] 37 (17) 49 (16) n/a ,0.001
$3 SIRS Criteria [n (%)] 75 (83.3) 241 (83.1) 1.0 (0.5–1.9) 0.96
HR.110 beats/min [n (%)] 70 (78.7) 190 (65.7) 1.9 (1.1–3.4) 0.02
RR.30 breaths/min [n (%)] 73 (82) 179 (62.2) 2.8 (1.5–5.0) 0.001
Temp.37.5uC[ n( % ) ]
{ 52 (58.4) 168 (58.7) 1.3 (0.8–2.3) 0.33
Temp,35.5uC[ n( % ) ]
{ 16 (18) 28 (9.8) 2.4 (1.1–5.3) 0.02
MAP,50 mmHg [n (%)] 24 (27.9) 43 (14.9) 2.2 (1.2–3.9) 0.01
Laboratory results
Positive Aerobic Cultures [n (%)] 14 (15.6) 33 (11.4) 1.4 (0.7–2.8) 0.29
HIV Positive [n (%)] 79 (89.8) 240 (83.3) 1.8 (0.8–3.8) 0.14
WBC.12,000 cells/mL [n (%)]‘ 16 (19) 41 (14.5) 1.7 (0.9–3.4) 0.12
WBC,4,000 cells/mL [n (%)]‘ 32 (38.1) 84 (29.7) 1.7 (1.0–2.9) 0.06
Hb [mean g/dL (SD)] 8.4 (4.0) 9.2 (3.1) n/a 0.04
Platelets,150,000 cells/mL [n (%)] 35 (42.2) 70 (25.2) 2.2 (1.3–3.6) 0.003
Positive Malaria Smear [n (%)] 13 (14.6) 38 (13.1) 1.1 (0.6–2.2) 0.72
Management
$1 Liter IV Fluid Provided at 6 Hours [n (%)] 35 (38.9) 95 (32.8) 1.3 (0.8–2.1) 0.28
$1 Liter IV Fluid Provided at 24 Hours [n (%)] 52 (62.7) 175 (62.7) 1.0 (0.6–1.6) 0.99
,1 Hour to Administration of Fluid [n (%)] 57 (64.0) 142 (49.0) 1.8 (1.1–3.0) 0.01
Empiric Antibiotics Administered [n (%)] 77 (86.5) 241 (84.3) 1.2 (0.6–2.4) 0.60
,1 Hour to Administration of Antibiotics [n (%)] 28 (31.5) 93 (32.6) 0.9 (0.6–1.6) 0.84
* Due to the occurrence of missing data found in ,2% of the variables, numbers may not add up to total n.
{ Compared to the normal range of temperature (i.e., 35.5–37.5uC).
‘ Compared to the normal range of WBC (i.e., 4,000–12,000 cells/ml).
n/a=not applicable.
doi:10.1371/journal.pone.0007782.t002
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hospital nor post-discharge mortality.
With respect to antibiotic susceptibilities, approximately 95% of
Salmonella isolates were resistant to chloramphenicol and trimeth-
oprim-sulfamethoxazole (TMP-SMX); none of the Staphylococcus
aureus samples were resistant to oxacillin. In a subset of patients
with positive aerobic cultures where susceptibilities were tested
(n=30), there was a trend towards decreased overall mortality in
patients receiving appropriate versus inappropriate empiric
antibacterials (18.2% vs. 50%, p=0.074).
Microbiology
Bacteremia was identified by aerobic and mycobacterial
cultures in 72 (18.9%) of 381 patients. Patients with bacteremia
were more likely to die while hospitalized than patients without
bacteremia [33.3% (24/72) vs. 21.4% (66/308), p=0.032; OR
1.83, 95%CI=1.01–3.33]. Organisms grown from aerobic
cultures were both Gram negative and Gram positive (n=48)
with the most frequently isolated organisms being non-typhoidal
Salmonella (20%), Staphylococcus aureus (12%) and Streptococcus
pneumoniae (6%) (see table 6).
Among patients with mycobacterial culture results, 55 (22.1%)
of 249 had mycobacteremia. Of these 55 patients, 45.5% had
MTB. When compared to patients without MTB positive cultures,
patients with MTB positive cultures had higher in-hospital
mortality [44.0% (11/25) vs. 22.3% (50/224), p=0.026; OR
1.97, 95% CI=1.19–3.27] as well as lower median CD4 counts
[8.0 vs. 47.0, Mann-Whitney p=0.001].
Approximately 13% (51/379) of patients had malaria parasit-
emia which mostly (86.3%) consisted of 1+ parasitemia; level of
malaria parasitemia was not associated with mortality (data
previously shown) [27].
Laboratory tests
Due to resource constraints, we only assessed metabolic status in
the 250 patients enrolled at Mulago. Table 7 shows the
relationship of measured laboratory values with respect to in-
hospital survival at Mulago Hospital. Multivariate analysis
revealed that increased cortisol and decreased albumin levels
were independent predictors of in-hospital mortality. None of the
laboratory variables were found to predict post-discharge mortality
(data not shown).
Discussion
This study is the first prospective evaluation of the management
and outcomes of patients with severe sepsis in a resource-constrained
setting. With respect to degree of fluid resuscitation and appropri-
ateness of empiric antibacterials,the management of septic patients in
our study was suboptimal and overall mortality was 43%, comprised
of both high in-hospital and post-discharge mortality.
While the mortality in this cohort is comparable to mortality
reported from cohorts in HICs, it is difficult to compare patients
from both settings given stark differences in age distribution. In
our study, the predominantly HIV-1 infected participants had a
mean age of ,35 years old with no evidence of cardiovascular
comorbidities. In contrast, studies from HICs report patients with
a mean age of 65 and multiple cardiovascular comorbidities. Thus,
Table 3. Multivariate analysis of clinical predictors for in-
hospital mortality.
Variable OR (95% CI) p
Glasgow Coma Score ,15 2.7 (1.2–6.3) 0.022
Mean Admission Karnofsky Score
* 0.6 (0.5–0.8) ,0.001
RR.30 breaths/min 2.3 (1.2–4.3) 0.012
WBC.12,000 cells/mL
‘ 2.8 (1.3–6.0) 0.01
Platelets,150,000 cells/ml 2.0 (1.1–3.6) 0.022
* Per 10-unit increase.
‘ Compared to the normal range of WBC (i.e., 4,000–12,000 cells/ml).
doi:10.1371/journal.pone.0007782.t003
Figure 2. In-hospital mortality and admission Karnofsky Performance Scale score. [*Numbers in bars represent number of patients.]
doi:10.1371/journal.pone.0007782.g002
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younger patient populations have more robust cardiovascular
systems than patients in older cohorts, making them less likely to
succumb during their hospitalization when presenting with severe
sepsis or septic shock.
Clinical predictors of in-hospital mortality included variables
easily measurable in any setting such as morbidity assessment
scales (i.e., KPS and GCS) and vital signs (i.e., RR.30 breaths/
min). Leukocytosis and thrombocytopenia were also predictive of
in-hospital mortality and have been previously shown to be good
outcome predictors of patients with septic shock in HIC settings
[31–33]. Their predictive value in identifying patients at risk for
mortality suggests that an admission CBC should be considered a
necessary component of initial laboratory investigations for
evaluating critically ill patients presenting to resource-constrained
hospitals.
Lack of material and human resources contributes to the
inability to achieve improved management of sepsis in resource-
constrained settings [17]. The high mortality associated with sepsis
syndromes in our study may have resulted from this lack of
materials and human resources necessary for optimal care. For
example, on a 50-bed ward at Mulago Hospital where the number
Table 4. Univariate analysis of clinical predictors for post-discharge mortality.
Variable Subcategory Died (n=55)
* Survived (n=192)
* OR (95% CI) p
Patient Demographic Characteristics
Female [n (%)] 38 (69.1) 109 (56.8) 1.7 (0.9–3.2) 0.10
Age [mean years (SD)] 32.8 (9.2) 35.6 (11.8) n/a 0.12
Marital Status [n (%)] Married or in Relationship 27 (50.0) 101 (53.4) 0.9 (0.5–1.6) 0.66
Unmarried or not in Relationship 27 (50.0) 88 (46.6)
Education [n (%)] None 5 (9.3) 15 (8.0) 0.6 (0.4–1.0) 0.23
Primary School 39 (72.2) 113 (60.1)
Secondary School 10 (18.5) 55 (29.3)
University 0 (0) 5 (2.7)
Hospital Site [n (%)] Mulago 38 (69.1) 108 (56.3) 1.7 (0.9–3.3) 0.09
Masaka 17 (30.9) 84 (43.8)
Medical Status
Glasgow Coma Score ,15 [n (%)] 1 (1.8) 13 (6.8) 0.2 (0.03–2.0) 0.16
Admit Karnofsky Score [mean (SD)] 41 (12) 52 (15) n/a ,0.001
Discharge Karnofsky Score [mean (SD)] 59 (16) 73 (14) n/a ,0.001
$3 SIRS Criteria [n (%)] 45 (81.8) 162 (84.4) 0.8 (0.4–1.8) 0.65
Admit HR .110 beats/min [n (%)] 37 (67.3) 120 (62.8) 1.2 (0.6–2.3) 0.54
Admit RR .30 breaths/min [n (%)] 35 (64.8) 117 (61.3) 1.2 (0.6–2.2) 0.63
Admit Temp .37.5uC[ n( % ) ]
{ 38 (69.1) 106 (55.8) 1.8 (0.9–3.6) 0.10
Admit Temp ,35.5uC[ n( % ) ]
{ 4 (7.5) 19 (10.0) 1.0 (0.3–3.6) 0.94
Admit MAP ,50 mmHg [n (%)] 12 (21.8) 21 (11.1) 2.2 (1.0–4.9) 0.04
Laboratory results
Positive Aerobic Cultures [n (%)] 6 (10.9) 27 (14.1) 0.7 (0.3–1.9) 0.54
HIV Positive [n (%)] 52 (94.5) 155 (81.6) 3.9 (1.2–13.3) 0.02
WBC.12,000 cells/mL [n (%)]‘ 3 (5.6) 28 (15.1) 0.4 (0.1–1.3) 0.11
WBC,4,000 cells/mL [n (%)]‘ 21 (38.9) 57 (30.6) 1.2 (0.6–2.4) 0.51
Hemoglobin [mean g/dL (SD)] 7.8 (0.3) 9.6 (0.2) n/a ,0.001
Platelets,150,000 cells/mL [n (%)] 17 (31.5) 44 (24.3) 1.4 (0.7–2.8) 0.29
Positive Malaria Blood Smear [n (%)] 7 (12.7) 29 (15.2) 0.8 (0.3–2.0) 0.65
Management
$1 Liter IV Fluid Provided at 6 Hours [n (%)] 20 (36.4) 60 (31.3) 1.2 (0.7–2.4) 0.48
$1 Liter IV Fluid Provided at 24 Hours [n (%)] 35 (66.0) 118 (62.8) 1.2 (0.6–2.2) 0.66
,1 Hour to Administration of Fluid [n (%)] 32 (58.2) 86 (44.8) 1.7 (0.9–3.1) 0.08
Empiric Antibiotics Administered [n (%)] 42 (76.4) 163 (85.8) 0.5 (0.2–1.1) 0.10
,1 Hour to Administration of Antibiotics [n (%)] 18 (32.7) 57 (30.2) 1.1 (0.6–2.1) 0.72
Duration of hospitalization [mean days (SD)] 8.8 (6.9) 7.5 (5.6) n/a 0.15
* Due to the occurrence of missing data found in ,2% of the variables, numbers may not add up to total n.
{ Compared to the normal range of temperature (i.e., 35.5–37.5uC).
‘ Compared to the normal range of WBC (i.e., 4,000–12,000 cells/ml).
n/a=not applicable.
doi:10.1371/journal.pone.0007782.t004
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patient ratio was less than 1:20 and the volume of IV fluids
provided to the ward per day was limited to 20 L. In addition, few
enrolled patients had access to supplemental oxygen, cardiovas-
cular support medications, or continuous monitoring.
Guidelines used in HICs for the management of severe sepsis
recommend that patients receive a minimum initial administration
of 20 mL/kg of crystalloid as a fluid challenge with subsequent
fluid challenges every 30 minutes for refractory hypotension within
the first 6 hours [14]. Although few studies have looked at the
direct effect of early fluid resuscitation volumes on clinical
outcomes of patients with sepsis, one study reported that septic
children receiving 40 mL/kg within the first hour of presentation
were significantly less likely to die than those receiving less fluid
[34]. Our adult patients (with an estimated mean weight of 50 kg)
did not come close to reaching that target, having received less
than 2 mL/kg/hr within the first 6 hours of presentation.
While it did not portend improved survival, early fluid
resuscitation (i.e., ,1hr vs. $1 hr) was found to significantly
predict mortality in patients discharged from the hospital.
Although the reason for this finding is not clear from our data,
we found that earlier fluid resuscitation was predicted by measures
of illness severity such as admission KPS. These data suggest that
sicker-appearing patients were more likely to receive early fluid
resuscitation. Even though this early fluid resuscitation may have
improved short-term survival for a proportion of patients while
hospitalized, these patients were more likely to die soon after
leaving the hospital suggesting that the patients’ underlying illness
was a contributor to their ultimate mortality. Though we did not
have complete data on patient comorbidities at the time of
admission, our blood culture data from Mulago Hospital suggest a
considerable proportion of patients (10%) presenting with sepsis
syndromes in Uganda have MTB bacteremia. This information
along with the associated high mortality and low CD4 counts
highlights a need to improve early case finding of co-infected HIV
and MTB patients in highly endemic areas like Uganda.
Antibacterial management also could have been better
optimized. Empiric antibacterial therapy was rarely concordant
with blood culture sensitivities. The trends we show are consistent
with several studies that have shown increased mortality in
bacteremic patients receiving inappropriate empiric antibacterials
[35,36].
While a majority of patients received antibacterials, improved
survival was neither found in patients receiving early antibacterials
nor any regimen of empiric antibacterials. There are several
possible reasons for these findings. For one, with the multitude of
different antibacterial regimens used, the benefit of an appropriate
antibacterial regimen could have been statistically outweighed by
the detriment of being administered an inappropriate regimen. In
addition, while data suggest that survival of septic patients
improves when antibacterials are provided within the first hour
of presentation, a small subset (,1/3) of study patients received
their antibacterials within this time frame [37]. Finally, we found
variability in the duration and availability of antibacterials when
patients are transferred from the Accident and Emergency
Department to the medical wards. While we did not collect this
information in detail, future studies in these settings are needed to
better describe the outcomes of patients with invasive bacterial
infections with respect to duration and type of antibacterials.
Table 5. Multivariate analysis of clinical predictors for post-
discharge mortality.
Variable OR (95% CI) p
Discharge Karnofsky Score
* 0.5 (0.4–0.7) ,0.001
Time to Administration of Fluid, ,1 hour 2.7 (1.2–5.9) 0.015
* Per 10-unit increase.
doi:10.1371/journal.pone.0007782.t005
Figure 3. Frequency of separate empiric antibiotic regimens used. [*Represents 35 separate regimens used ,1% of the time; Pen/
Gent=Penicillin/Gentamicin; Pen/TMP-SMX=Penicillin/Trimethoprim-Sulfamethoxazole; Amp/Metro=Ampicillin/Metronidazole, Amp/Gent=Am-
picllin/Gentamicin, Chlor/Pen=Chloramphenicol/Penicillin; Cipro/TMP-SMX=Ciprofloxacin/Trimethoprim-Sulfamethoxazole, Cipro/Metro=Ciproflox-
acin/Metronidazole; TMP-SMX=Trimethoprim-Sulfamethoxazole]
doi:10.1371/journal.pone.0007782.g003
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spectrum coverage, chloramphenicol is an attractive antibacterial
for empiric coverage of bacteremia and has been recommended by
the World Health Organization in algorithms for empiric coverage
of febrile illnesses [38,39]. In light of the increased prevalence of
non-typhoidal Salmonella bacteremia (43% of positive aerobic
blood cultures) with the majority of isolates resistant to
chloramphenicol, our data along with others suggest that use of
chloramphenicol for empiric coverage of Gram negative organ-
isms should be reevaluated [40]. We agree with others who argue
for improved microbiologic capabilities in strategically located
sentinel hospitals to better characterize local antimicrobial
resistance patterns and identify appropriate empiric antibacterial
regimens [6,16].
While our microbiology results are similar to previous studies of
bacteremia in hospitalized patients conducted in SSA, a limitation
in our study was a low prevalence of culture-positive sepsis (,20%)
[5,7–10,12,41,42]. Notably, low blood culture yields have been
shown in sepsis studies in other settings [6,13,43]. Additionally,
more than half of the study patients (57.7%) reported taking some
type of antibacterial prior to hospital admission. Self treatment
with easily accessible over-the-counter antimicrobials has been
described in this region [44–46]. Further research on this type of
drug utilization could provide important insight into antibacterial
susceptibility patterns in this setting. In addition, although
budgetary constraints prevented us from obtaining them, cultures
from other sources could have provided more information on
microbiologic etiology of patients who presented with a sepsis
syndrome despite having negative blood cultures. Given the
inability to predict with certainty which patients are likely to
succumb to their illness, however, we strongly believe that all
patients presenting with the syndrome captured by our inclusion
criteria (regardless of culture results) should be ultimately managed
early and aggressively in order to avoid death.
Another limitation was the proportion of patients lost to follow
up, with 43 of 45 lost patients being from Mulago Hospital. The
difference in patients lost to follow-up between sites is likely due to
the size of their respective encatchment areas and the ease with
which hospital staff can track patients after discharge in a smaller,
more rural encatchment area (i.e., MRRH) versus a larger, more
urban encatchment area (i.e., Mulago Hospital), especially when
patients do not have mobile telephones. Future studies will need to
find ways of improving the ability to track patients in order to
optimize measurement of survival after patients leave the hospital.
Our study suggests mortality due to severe sepsis was high in a
significant proportion of HIV-infected patients admitted to
Ugandan medical wards. Furthermore, a considerable number
of patients were unaware of their serostatus and only a small
percentage was taking highly-active antiretroviral therapy
(HAART). These data point to the importance of targeting
patients who access hospital-based care for potential HIV
treatment and prevention measures. While the benefits of HAART
scale-up are becoming increasingly realized in patients who are on
therapy, more than 2 million young men and women continue to
die annually from HIV-related diseases (e.g., sepsis) [47]. In the
current era of HAART scale-up in SSA, improvement in sepsis
management may create a window of opportunity for later access
to life-saving HIV therapy.
Achieving this goal in settings like Uganda cannot occur unless
there is a targeted approach to the management of hospitalized
patients with diseases such as sepsis. Thus, focusing on being able
to clinically identify this syndrome alongside appropriate man-
agement should be paramount during the training and education
of all health workers who manage patients similar to those in our
study. Such an approach will be most effective alongside the
procurement of low cost, high impact and readily available
modalities like IV fluids and appropriate antibiotics, improvement
in laboratory capabilities, and closer monitoring with increased
health personnel.
Table 6. Number and percentage of organisms grown from
aerobic blood culture.
Organism Total (n=48)
Non-typhoidal Salmonella species [n (%)] 20 (42.6)
Staphylococcus aureus [n (%)] 12 (25.5)
Streptococcus pneumonia [n (%)] 6 (12.8)
Escherichia coli [n (%)] 4 (8.5)
Proteus species [n (%)] 1 (2.1)
Cryptococcus neoformans [n (%)] 5 (10.6)
doi:10.1371/journal.pone.0007782.t006
Table 7. Univariate and multivariate analysis for admission laboratory predictors of in-hospital mortality at Mulago Hospital.
Univariate Predictors Multivariate Predictors
*
Variable Death Survival p Odds Ratio (95% CI) p
Sodium in mEq/L [mean (SD)] 131.3 (6.7) 132.0 (5.4) 0.47
Potassium in mEq/L [mean (SD)] 4.2 (0.8) 4.1 (0.6) 0.58
Chloride in mmol/L [mean (SD)] 95.8 (5.2) 97.3 (4.3) 0.02 — n.s.
Bicarbonate in mmol/L [mean (SD)] 21.1 (3.1) 21.2 (2.9) 0.84
Blood urea nitrogen in mg/dL [mean (SD)] 10.1 (7.3) 8.2 (8.0) 0.10 — n.s.
Creatinine in umol/L [mean (SD)] 127.4 (105.9) 113.9 (85.6) 0.32
Glucose in mg/dL [mean (SD)] 122.7 (72.6) 126.2 (66.6) 0.79
Cortisol in nmol/L [mean (SD)] 425.4 (147.0) 318.5 (133.1) ,0.001 1.01 (1.0–1.01) ,0.001
Albumin in g/dL [mean (SD)] 3.0 (0.5) 3.3 (0.6) 0.002 0.2 (0.1–0.5) ,0.001
* Model is adjusted for covariates found to be significant predictors of in-hospital mortality (i.e., unmarried marital status, decreased admission KPS, and RR.30 breaths/
min) in a multivariate analysis for the general Mulago Hospital model (data not shown).
n.s.=not significant.
doi:10.1371/journal.pone.0007782.t007
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